1. Home
  2. DAIO vs LNAI Comparison

DAIO vs LNAI Comparison

Compare DAIO & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$3.18

Market Cap

23.4M

Sector

Industrials

ML Signal

N/A

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$1.10

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAIO
LNAI
Founded
1969
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
23.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DAIO
LNAI
Price
$3.18
$1.10
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.22
N/A
AVG Volume (30 Days)
26.6K
3.0M
Earning Date
10-30-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,701,000.00
N/A
Revenue This Year
$9.14
N/A
Revenue Next Year
$2.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$0.81
52 Week High
$3.57
$20.40

Technical Indicators

Market Signals
Indicator
DAIO
LNAI
Relative Strength Index (RSI) 63.46 N/A
Support Level $2.86 N/A
Resistance Level $3.20 N/A
Average True Range (ATR) 0.15 0.00
MACD 0.06 0.00
Stochastic Oscillator 94.55 0.00

Price Performance

Historical Comparison
DAIO
LNAI

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: